LOGEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Logen, and what generic alternatives are available?
Logen is a drug marketed by Superpharm and is included in one NDA.
The generic ingredient in LOGEN is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for LOGEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 60 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LOGEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LOGEN
US Patents and Regulatory Information for LOGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Superpharm | LOGEN | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 088962-001 | May 10, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |